A systematic review of the emerging definition of 'deprescribing' with network analysis: Implications for future research and clinical practice.

British Journal of Clinical Pharmacology

Volumn 80, Issue 6, 2015, Pages 1254-1268

  Reeve, Emily ^a   Gnjidic, Danijela ^b   Long, Janet ^a   Hilmer, Sarah ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

deprescribing; health care definitions; inappropriate medication use; network analysis; polypharmacy

Indexed keywords

ANALYSIS; CINAHL; CLINICAL PRACTICE; CLINICAL RESEARCH; DEPRESCRIPTION; EMBASE; HUMAN; MEDLINE; NETWORK ANALYSIS; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SCOPUS; SYSTEMATIC REVIEW; POLYPHARMACY; RESEARCH;

DEPRESCRIPTIONS; HUMANS; POLYPHARMACY; RESEARCH;

EID: 84957438911     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/bcp.12732     Document Type: Review

References (64)

1. Woodward M,. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res 2003; 33: 323-8.
2. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA,. Guide to good prescribing. Geneva: World Health Organization, 1995.
3. Maher RL, Hanlon J, Hajjar ER,. Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 2014; 13: 57-65.
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM,. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004; 329: 15-9.
5. Payne R, Avery A, Duerden M, Saunders C, Simpson C, Abel G,. Prevalence of polypharmacy in a Scottish primary care population. Eur J Clin Pharmacol 2014; 70: 575-81.
6. Cahir C, Bennett K, Teljeur C, Fahey T,. Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients. Br J Clin Pharmacol 2014; 77: 201-10.
7. Beer C, Hyde Z, Almeida OP, Norman P, Hankey GJ, Yeap BB, Flicker L,. Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study. Br J Clin Pharmacol 2011; 71: 592-9.
8. Chang C-B, Chan D-C,. Comparison of published explicit criteria for potentially inappropriate medications in older adults. Drugs Aging 2010; 27: 947-57.
9. Tjia J, Briesacher BA, Peterson D, Liu Q, Andrade SE, Mitchell SL,. Use of medications of questionable benefit in advanced dementia. JAMA Internal Med 2014; 174: 1763-71.
10. Steinman MA, Hanlon JT,. Managing medications in clinically complex elders: "There's got to be a happy medium". JAMA 2010; 304: 1592-601.
11. Farrell B, Monahan A, Thompson W,. Revisiting medication use in a frail 93-year-old man experiencing possible adverse effects. Can Med Assoc J 2014; 186: 445-9.
12. Hilmer SN, Gnjidic D, Le Couteur DG,. Thinking through the medication list-Appropriate prescribing and deprescribing in robust and frail older patients. Aust Fam Physician 2012; 41: 924.
13. Gnjidic D, Le Couteur DG, Hilmer SN,. Discontinuing drug treatments. BMJ 2014; 349: g7013.
14. Ostini R, Hegney D, Jackson C, Tett SE,. Knowing how to stop: ceasing prescribing when the medicine is no longer required. J Manag Care Pharm 2012; 18: 68-72.
15. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD,. Review of deprescribing processes and development of an evidence based, patient-centred deprescribing process. Br J Clin Pharmacol 2014; 78: 738-47.
16. Moher D, Liberati A, Tetzlaff J, Altman DG,. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
17. Hsieh H-F, Shannon SE,. Three approaches to qualitative content analysis. Qual Health Res 2005; 15: 1277-88.
18. Long JC, Cunningham FC, Carswell P, Braithwaite J,. Patterns of collaboration in complex networks: the example of a translational research network. BMC Health Serv Res 2014; 14: 225.
19. Newman ME,. Coauthorship networks and patterns of scientific collaboration. Proc Natl Acad Sci 2004; 101: 5200-5.
20. Greenberg SA,. How citation distortions create unfounded authority: analysis of a citation network. BMJ 2009; 339.
21. Bain KT, Holmes HM, Beers MH, Maio V, Handler SM, Pauker SG,. Discontinuing medications: A novel approach for revising the prescribing stage of the medication-use process. J Am Geriatr Soc 2008; 56: 1946-52.
22. Le Couteur DG, Ford GA, McLachlan AJ,. Evidence, ethics and medication management in older people. J Pharm Pract Res 2010; 40: 148-52.
23. Scott I, Jayathissa S,. Quality of drug prescribing in older patients: Is there a problem and can we improve it? Intern Med J 2010; 40: 7-18.
24. Boparai MK, Korc-Grodzicki B,. Prescribing for older adults. Mt Sinai J Med 2011; 78: 613-26.
25. Hardy JE, Hilmer SN,. Deprescribing in the Last Year of Life. J Pharm Pract Res 2011; 41: 146-51.
26. Le Couteur D, Banks E, Gnjidic D, McLachlan A,. Deprescribing. Australian Prescriber 2011; 34: 182-5.
27. Geller AI, Nopkhun W, Dows-Martinez MN, Strasser DC,. Polypharmacy and the role of physical medicine and rehabilitation. PM&R 2012; 4: 198-219.
28. Gnjidic D, Hilmer SN, Le Couteur DG,. High-risk prescribing in older people: More harm than good? Aging Health 2012; 8: 325-7.
29. Gnjidic D, Le Couteur DG, Kouladjian L, Hilmer SN,. Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes. Clin Geriatr Med 2012; 28: 237-53.
30. Pond D, Dementia an update on management. Aust Fam Physician 2012; 41: 936-9.
31. Russell T,. Managing multiple morbidities. Australian Pharmacist 2012; 31.
32. Woodward M, Sleep in older people. Rev Clin Gerontol 2012; 22: 130-49.
33. Booth J,. DrugScan: Geriatrics J Pharm Pract Res 2013; 43.
34. Hilmer S, Gnjidic D,. Statins in older adults. Australian Prescriber 2013; 36: 79-82.
35. Kouladjian L,. The drug burden index: A new tool for HMRs? Australian Pharmacist 2013; 32.
36. Lees J,. Management of polypharmacy in older cancer patients. Cancer Forum 2013; 37: 230-3.
37. Scott IA, Gray LC, Martin JH, Pillans PI, Mitchell CA,. Deciding when to stop: towards evidence-based deprescribing of drugs in older populations. Evid Based Med 2013; 18: 121-4.
38. Somma C, Trillini M, Kasa M, Gentile G,. Managing end-stage renal disease in the elderly: State-of-the-art, challenges and opportunities. Aging Health 2013; 9: 539-52.
39. Thompson W, Farrell B,. Deprescribing: what is it and what does the evidence tell us? Can J Hosp Pharm 2013; 66.
40. Alldred DP,. Deprescribing: A brave new word? Int J Pharm Pract 2014; 22: 2-3.
41. Liu LM,. Deprescribing: An approach to reducing polypharmacy in nursing home residents. J Nurs Practitioners 2014; 10: 136-9.
42. Reeve E, Wiese MD,. Benefits of deprescribing on patients' adherence to medications. Int J Clin Pharm 2014; 36: 26-9.
43. Iyer S, Naganathan V, McLachlan AJ, Le Conteur DG,. Medication withdrawal trials in people aged 65 years and older. Drugs Aging 2008; 25: 1021-31.
44. Reeve E, To J, Hendrix I, Shakib S, Roberts M, Wiese M,. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging 2013; 30: 793-807.
45. Lindsay J, Dooley M, Martin J, Fay M, Kearney A, Barras M,. Reducing potentially inappropriate medications in palliative cancer patients: evidence to support deprescribing approaches. Support Care Cancer 2014; 22: 1113-9.
46. Boisdin E, Dufour M, Doucet J,. Can general practitioners 'deprescribe' drugs? Results of a preliminary prospective study. Fundam Clin Pharmacol 2012; 26: 86.
47. Manias E,. Complexities of pain assessment and management in hospitalised older people: a qualitative observation and interview study. Int J Nurs Stud 2012; 49: 1243-54.
48. Manias E, Kusljic S, Berry C, Brown E, Bryce E, Cliffe J, Smykowsky A,. Use of the Screening Tool of Older Person's Prescriptions (STOPP) in older people admitted to an Australian hospital. Australas J Ageing 2013; 34: 15-20.
49. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD,. Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. Int J Clin Pharm 2013; 35: 51-6.
50. Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S,. People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc 2013; 61: 1508-14.
51. Turner J, Singhal N, Bell JS,. Opportunities for deprescribing statins in patients with poor cancer prognosis. J Pall Med 2013; 16: 1328.
52. Medicines Management Team at the CCG. Prescribing Spotlight. High Weald Lewes Havens Clinical Commissioning Group NHS newsletter: East Sussex, UK, 2013: 3.
53. Richardson T, Emberley P, Farrell B, Schuling J, Wodchis W, LeBlanc C, Dalgleish C,. The translator: the role of pharmacists in deprescribing. The Translator 2013; 7.
54. Page MA,. Prescribing in teaching hospitals: exploring social and cultural influences on practices and prescriber training. 2010.
55. Riker G,. Deprescribing: The war on polypharmacy. ASCP Annual Meeting, Seattle, WA, USA. 2013.
56. Laroche ML, Charmes JP, Bouthier F, Merle L,. Inappropriate medications in the elderly. Clin Pharmacol Ther 2008; 85: 94-7.
57. Higashi T, Shekelle PG, Solomon DH, Knight EL, Roth C, Chang JT, Kamberg CJ, MacLean CH, Young RT, Adams J,. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004; 140: 714-20.
58. Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT,. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370: 173-84.
59. Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD,. The benefits and harms of deprescribing. Med J Aust 2014; 201: 386-9.
60. Declercq T, Petrovic M, Azermai M, Vander Stichele R, De Sutter AI, van Driel ML, Christiaens T,. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Cochrane Database Syst Rev 2013; 3: CD007726.
61. Kutner JS, Blatchford PJ, Taylor DH Jr, Ritchie CS, Bull JH, Fairclough DL, Hanson LC, LeBlanc TW, Samsa GP, Wolf S, Aziz NM, Currow DC, Ferrell B, Wagner-Johnston N, Zafar SY, Cleary JF, Dev S, Goode PS, Kamal AF, Kassner C, Kvale EA, McCallum JG, Ogunseitan AB, Pantilat SZ, Portenoy RK, Prince-Paul M, Sloan JA, Swetz KM, Von Gunten CF, Abernethy AP,. Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness: A randomized clinical trial. JAMA Internal Med 2015; 175: 691-700.
62. Anderson K, Freeman C, Stowasser D, Scott I,. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: A systematic review and thematic synthesis. BMJ Open 2014; 4: e006544.
63. Scott I, Gray L, Martin J, Mitchell C,. Minimizing inappropriate medications in older populations: A 10-step conceptual framework. Am J Med 2012; 125: 529-37.
64. Schuling J, Gebben H, Veehof LJG, Haaijer-Ruskamp FM,. Deprescribing medication in very elderly patients with multimorbidity: The view of Dutch GPs. A qualitative study. BMC Fam Pract 2012; 13: 56.